Background illustration for clinical trials search

Lung Cancer Clinical Trials

Browse 2,144 lung cancer clinical trials enrolling across the United States and Canada. Search by city or state to find one near you.

Filter
1

Study of SGR-3515 In Participants With Advanced Solid Tumors.

for
Advanced Solid Tumor
Location: New Haven CT, New York NY, Fairfax VA, Toronto,
Sponsor: Schrödinger, Inc.

Sex: All

Age: 18+

Code: NCT06463340

Phase 1, Recruiting

A Study to Evaluate the Safety, Pharmacokinetics, and Anti-Tumor Activity of VVD-133214 as Monotherapy and in Combination in Participants With Advanced Solid Tumors

for
Advanced Solid Tumors, Colorectal Cancer
Location: New Brunswick NJ, Toronto, Atlanta GA, Ann Arbor MI,
Sponsor: Vividion Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT06004245

Phase 1, Recruiting

A Study of Azenosertib (ZN-c3) in Patients With Ovarian Cancer

for
Solid Tumor, Epithelial Ovarian Cancer, Fallopian Tube Cancer,
Location: Boston MA, Providence RI, New York NY, Durham NC,
Sponsor: K-Group, Beta, Inc., a wholly owned subsidiary of Zentalis Pharmaceuticals, Inc

Sex: Female

Age: 18+

Code: NCT04516447

Phase 1, Recruiting

Study to Evaluate Maximum Tolerated Dose of Oral CB-03-10 With Dose Expansion Phase, in Advanced Solid Tumors

for
Advanced Refractory Solid Tumors,
Location: New Haven CT, Ohio City OH, Michigan Center MI,
Sponsor: Cosmo Technologies Ltd

Sex: All

Age: 18+

Code: NCT03863145

Early Phase 1, Recruiting

Bromelain, Comosain as a New Drug for Treating and Preventing Various Types of Cancer in the Humans

for
Cancer
Location: West Covina CA
Sponsor: Oeyama-Moto Cancer Research Foundation

Sex: All

Age: 18 - 70+

Code: NCT02340845

Phase 2, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

A Phase 2 Study of Zanidatamab in Patients With HER2-expressing Tumors

for
Breast Cancer, Gastric Cancer, Esophageal Cancer,
Location: Lake Success NY, New York NY, Nashville TN, Westwood KS,
Sponsor: Jazz Pharmaceuticals

Sex: All

Age: 18+

Code: NCT06695845

Phase 2, Recruiting

FOCUS for Pediatric Sickle Cell Disease and Cancer

for
Pediatric Cancer, Sickle Cell Disease, Quality of Life,
Location: Atlanta GA
Sponsor: Georgia State University

Sex: All

Age: 12 - 18

Code: NCT04075877

Recruiting

Open-label, Single Center, Single-arm, Phase 2 Study of Neoadjuvant Pembrolizumab in Combination With Carboplatin and Paclitaxel in Patients With Stage 1 cT1b-T1cN0M0 Triple Negative Breast Cancer

for
Stage 1 cT1b-T1cN0M0, Triple Negative Breast Cancer
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center

Sex: All

Age: 18+

Code: NCT06318897

Phase 2, Recruiting

QTX3034 in Patients With KRAS G12D Mutation

for
Solid Tumors
Location: New Haven CT, The Bronx NY, New York NY, Fairfax VA,
Sponsor: Quanta Therapeutics

Sex: All

Age: 18+

Code: NCT06227377

Phase 1, Recruiting

A Phase I Open-Label, Single-Arm, Dose-Escalation Clinical and Pharmacology Study of CCI-001 as Monotherapy and in Combination With Standard Chemotherapy in Patients With Recurrent and/or Metastatic Solid Tumours

for
Cancer: Recurrent and/or Metastatic Solid Tumours
Location: Edmonton
Sponsor: PharmaMatrix Holdings Ltd

Sex: All

Age: 18+

Code: NCT04823897

Phase 1, Recruiting

Phase 1 Study of OP-3136 in Advanced or Metastatic Solid Tumors

for
Advanced or Metastatic ER+ HER2- Breast Cancer (mBC),
Location: Boston MA, New York NY, Sarasota FL, Columbus OH,
Sponsor: Olema Pharmaceuticals, Inc.

Sex: All

Age: 18+

Code: NCT06784193

Phase 1, Recruiting

Evaluating Genomic Testing in Human Cancer & Outcomes of Targeted Therapies

for
Cancer
Location: Lexington KY
Sponsor: Rachel Miller

Sex: All

Age: 18+

Code: NCT03089554

Phase 2, Recruiting

Stereotactic Radiosurgery and Systemic Dose Chemotherapy for Locally Advanced Lung Cancer

for
Non Small Cell Lung Cancer
Location: Camden NJ
Sponsor: The Cooper Health System

Sex: All

Age: 18+

Code: NCT02568033

Early Phase 1, Recruiting

Tempus Small Cell Lung Cancer Observational Study (Sculptor)

for
Small Cell Lung Cancer
Location: Baltimore MD, York PA, Chapel Hill NC, Columbus OH,
Sponsor: Tempus AI

Sex: All

Age: 18+

Code: NCT05257551

Recruiting

Specimen Collection From Patients With Non-Hematologic Cancer for Use in Development of a Liquid Biopsy Assay

for
Non-hematologic Cancer
Location: Boise ID
Sponsor: Sequenom, Inc.

Sex: All

Age: 18+

Code: NCT02586389

Recruiting

Fatty Acid Synthase Inhibition in Castration Refractory Prostate Cancer

for
Prostate Cancer, Refractory Cancer,
Location: Winston-Salem NC, Salisbury NC
Sponsor: Wake Forest University Health Sciences

Sex: Male

Age: 18+

Code: NCT04337580

Phase 2, Recruiting

Clinical Study To Further Evaluate The Efficacy Of Dabrafenib Plus Trametinib In Patients With Rare BRAF V600E Mutation-Positive Unresectable or Metastatic Solid Tumors

for
Rare Unresectable or Metastatic BRAF V600E Mutation-positive Solid Tumors,
Location: Washington D.C. DC, Durham NC, Cincinnati OH,
Sponsor: Novartis Pharmaceuticals

Sex: All

Age: 1 - 70+

Code: NCT05868629

Recruiting

A Prospective Real World Evidence Study (PROWES) for Concordance Rate of Blood-based 3D Genome Conformation Mapping (Episwitch CiRT®) to Identify Likelihood of Response and Actual Response Rates to PD-(L)-1 Checkpoint Inhibitors Across Multiple Oncological Indications.

for
Cancer, Immunotherapy, PD-1, PD-L1, Immune Checkpoint Therapy
Location: Norwich CT, Rock Hill SC, Dublin GA
Sponsor: Oxford Biodynamics Inc.

Sex: All

Age: 18+

Code: NCT06635954

Recruiting

A Biospecimen Collection Study of Leukapheresis-Derived Circulating Tumor Cells, Immune Cells, and Progenitor Cells.

for
Solid Tumor, Adult, Healthy Donors, COVID-19 Donors
Location: Huntersville NC
Sponsor: BioCytics, Inc.

Sex: All

Age: 5+

Code: NCT00571389

Recruiting

Safety of Pentoxifylline and Vitamin E With Stereotactic Ablative Radiotherapy (SABR) in Non-small Cell Lung Cancers

for
Non-small Cell Lung Cancers
Location: Louisville KY
Sponsor: University of Louisville

Sex: All

Age: 18+

Code: NCT01871454

Phase 2, Recruiting

What is lung cancer?

Lung cancer starts when cells in the airways or lungs grow out of control. About 229,000 Americans will be diagnosed in 2026. There are two main types: non small cell lung cancer, about 85 percent of cases, and small cell lung cancer, which grows and spreads faster and is treated differently. Smoking causes most cases, but 10 to 20 percent happen in people who never smoked, from causes like radon, air pollution, or genetic changes. Most people are diagnosed around age 70.

Two things changed treatment. First, many lung cancers are driven by a single gene change, and pills that target that specific change can control the cancer for years, so tumors are now routinely tested for these changes before treatment starts. Second, immunotherapy works especially well in lung cancer, and some people with advanced disease are alive and well more than five years later. New targeted drugs kept getting approved through 2025, which is why lung cancer has more recruiting trials than any cancer except breast cancer.

Types of lung cancer clinical trials

Who can participate in lung cancer clinical trials?

What causes lung cancer?

Does vaping cause lung cancer?

The stages of lung cancer, and why they matter for trials

How to enroll in a lung cancer clinical trial